Table 1.
Demographics and clinical characteristics of the study population (n = 91, persistence 2, recurrence 1)
| Characteristic | Value |
|---|---|
| Age, yr | 48.9 ± 10.3 |
| Male sex | 46 (50.5) |
| Body weight, kg | 58.1 ± 10.4 |
| Dialysis duration, yr | 12.8 ± 5.6 |
| Hemodialysis | 80 (87.9) |
| Diabetes mellitus | 8 (8.8) |
| Blood pressure | |
| Systolic blood pressure, mmHg | 131.7 ± 18.3 |
| Diastolic blood pressure, mmHg | 78.7 ± 10.1 |
| Bone mineral density score | –2.9 ± 1.7 |
| Preoperative laboratory data | |
| Ca, mg/dL | 10.6 ± 1.3 |
| Ionized calcium, mg/dL | 5.0 ± 0.5 |
| Phosphorus, mg/dL | 5.9 ± 1.7 |
| ALP, IU/L (reference value, 8–76) | 313.6 ± 308.1 |
| Albumin, g/dL | 4.1 ± 0.8 |
| Parathyroid hormone, pg/mL | 1,385.5 (154.6–1,742.4) |
| Hemoglobin, g/dL | 11.0 ± 1.6 |
| Phosphate binders (n = 94) | |
| Al containing phosphate binders | 10 (10.6) |
| Ca containing phosphate binders | 28 (29.8) |
| Sevelamer | 26 (27.7) |
| Lanthanum | 19 (20.2) |
| None | 11 (11.7) |
| Vitamin D (n = 94) | |
| Cholecalciferol | 3 (3.2) |
| Calcitriol | 29 (30.9) |
| Pericalcitol | 24 (25.5) |
| Cinacalcet | 6 (6.4) |
| None | 32 (34.0) |
Values are presented as mean ± SD, number (%), or median (range).
ALP, alkaline phosphatase.